📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Infographic: Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: the ANCHOR study (2023)

First Author: Yusuf I

Attributed to: Development of AAV gene therapy for blindness caused by cone-rod dystrophy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41433-023-02397-z

PubMed Identifier: 37095277

Publication URI: http://europepmc.org/abstract/MED/37095277

Type: Journal Article/Review

Parent Publication: Eye

Issue: S2

ISSN: 0950-222X